Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Shan Ming Wu"'
Publikováno v:
Sleep Medicine. 100:254-261
Whether preexisting sleep disorder is an independent risk factor for cancer remains unclear. Therefore, we performed this propensity score-matched population-based cohort study to compare the incidence rate ratios (IRRs) of specific cancers between p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d55d8bc764fe097635dea607a70cc86d
https://doi.org/10.1016/j.sleep.2022.08.014
https://doi.org/10.1016/j.sleep.2022.08.014
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xu Min Zhao, Bo Wei, George J. Hanna, Zhong Ping Duan, Sheng Mei Mu, Ji Dong Jia, Lai Wei, Paul Ingravallo, Peggy Hwang, Zhan Sheng Jia, Li Wen Liang, Michael N. Robertson, Wen Xie, Ying Ren Zhao, Shan Ming Wu, Rohit Talwani, Wen Xiang Huang, Amy Puenpatom, Yan Huang, Ernest Asante-Appiah, Barbara Evans, Ming Xiang Zhang, Mao Rong Wang, Jun Qi Niu, Fu-Sheng Wang, Zaiqi Wang
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim In China, clinical experience with direct‐acting antiviral treatments for hepatitis C virus (HCV) infection is still emerging. C‐CORAL is a phase 3, multinational, placebo‐controlled, double‐blind trial of elbasvir/grazopre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd008fb92eaa0150b94267e8de9f853a
http://europepmc.org/articles/PMC7731814
http://europepmc.org/articles/PMC7731814
Autor:
Qing Guo, Hui Wang, Shan-Ming Wu, Xia-Qiu Zhou, Guo-Guang Xu, Yan Zhuang, Y. Liu, Bei Xu, Shisan Bao, Wei Cai, Lanyi Lin, Qing Xie
Publikováno v:
Journal of Gastroenterology and Hepatology. 30:372-378
Background and Aim Antiviral therapy is important in advanced liver fibrosis/cirrhosis with chronic hepatitis B (AdLF-CHB) patients, but complete regression of cirrhosis remains to be the challenge. We aimed to investigate whether up to 10 years lami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84a419c6e2e91eba282296900a585cea
https://doi.org/10.1111/jgh.12718
https://doi.org/10.1111/jgh.12718
Autor:
Qinhuan Wang, Yuhong Dong, Yuming Wang, Lai Wei, Chengwei Chen, W. Bao, X.J. Zhou, Junqi Niu, Jidong Jia, Aldo Trylesinski, Yong-wen He, You-Kuan Yin, Li-Min Zhu, Jinlin Hou, Deming Tan, Shan-Ming Wu, Dao-Zhen Xu, Hong Ren, Mobin Wan
Publikováno v:
Hepatology international. 8(1)
The burden of chronic hepatitis B infection is high in China, where prevalence exceeds 7 %. This was a randomized, double-blinded, phase III study of the efficacy and safety of telbivudine and lamivudine treatment at 104 weeks in Chinese patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1689a45f2863763aae74a1f154c8994
https://pubmed.ncbi.nlm.nih.gov/26202408
https://pubmed.ncbi.nlm.nih.gov/26202408
Publikováno v:
2012 24th Chinese Control and Decision Conference (CCDC).
In view of the current Cadet assessment of the actual demand, this paper based on the theory of fuzzy set, combining Agent technology, the technology of artificial intelligence expert system puts forward a comprehensive evaluation on students new ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa3103212b022586a821fd04f6781a26
https://doi.org/10.1109/ccdc.2012.6244493
https://doi.org/10.1109/ccdc.2012.6244493
Autor:
Guo-Guang, Xu, Shan-Ming, Wu, Xia-Qiu, Zhou, Qing-Bo, Zhang, Lai-Yi, Kang, Xiao-Ming, Zhou, Yin, Jiang, Xun, Qi, Xiao-Jing, Ren
Publikováno v:
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 32(4)
To investigate the clinical-epidemiologic characteristics of patients with hepatitis C virus (HCV) infection by post blood transfusion.Polymerase chain reaction (PCR) and enzyme linked immunosorbent assay (ELISA) were used to detect HCV RNA and anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::617c3fa6d12c0393101568a871fc5cb2
https://pubmed.ncbi.nlm.nih.gov/21569673
https://pubmed.ncbi.nlm.nih.gov/21569673
Autor:
Yi-min, Mao, Min-de, Zeng, Yong, Chen, Cheng-wei, Chen, Qing-chun, Fu, Xiong, Cai, Shan-ming, Wu, Ya-gang, Chen, Ying, Sun, Jun, Li, Yan-hua, Sui, Wei, Zhao, Lun-gen, Lu, Ai-ping, Cao, Hong-zhuan, Chen
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 17(11)
To evaluate the efficacy and safety of Magnesium isoglycyrrhizinate in treatment of chronic liver diseases.It is a randomized, double-blind, multi-doses, active drug controlled, multi-center study. 480 proper patients were randomly divided into group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::30fe31888628eed3019afa3dea040d2d
https://pubmed.ncbi.nlm.nih.gov/19958646
https://pubmed.ncbi.nlm.nih.gov/19958646
Autor:
Barbara Fielman Constance, Deming Tan, You-Kuan Yin, Mo-Bin Wan, George Harb, Shan-Ming Wu, Yagang Chen, Jia-zhang Xu, Nathaniel A. Brown, George C. Chao, Limin Zhu, X.J. Zhou, Yong-wen He, Yuming Wang, Cheng-Wei Chen, Jinlin Hou, Qinhuan Wang, Hong Ren, Jidong Jia, Dao-Zhen Xu, Junqi Niu, Lai Wei
Publikováno v:
Hepatology (Baltimore, Md.). 47(2)
Chronic hepatitis B and its life-threatening sequelae are highly prevalent in China. There is a need for effective new therapies to suppress hepatitis B virus (HBV) replication and ameliorate liver disease. In this study, we compared the efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46c6e7400c7aea205d3e2a76cf8e46df
https://pubmed.ncbi.nlm.nih.gov/18322938
https://pubmed.ncbi.nlm.nih.gov/18322938
Autor:
Ji-dong, Jia, Jin-lin, Hou, You-kuan, Yin, Dao-zhen, Xu, De-ming, Tan, Jun-qi, Niu, Xia-qiu, Zhou, Yu-ming, Wang, Li-min, Zhu, Yong-wen, He, Hong, Ren, Mo-bin, Wan, Cheng-wei, Chen, Shan-ming, Wu, Ya-gang, Chen, Jia-zhang, Xu, Qin-huan, Wang, Lai, Wei, Hong, Ma
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 15(5)
To investigate the possibilities of an association between the degrees of HBV suppression with nucleoside treatments at week 24 and week 52 in hepatitis B patients and to find a useful predictor for treatment efficacy.In this phase III, double-blind,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1cc321ed96f0ecd743e12678416c6636
https://pubmed.ncbi.nlm.nih.gov/17524265
https://pubmed.ncbi.nlm.nih.gov/17524265